Also from this source

You just read:

SanBio Announces Site Opening of Phase 1/2a Clinical Trial of Novel Cell Therapy in Stable Stroke Patients at University of Pittsburgh Medical Center

News provided by

SanBio, Inc.

Sep 20, 2011, 08:30 ET